LCTX · Lineage Cell Therapeutics, Inc. · Documents
$1.00
+0.02 (+1.52%)
At close · Oct 23
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$252.91M
Shares
252.91M
Volume · Oct 23
1.15M
Avg daily vol (3M)
1.25M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3 | — | 2024-03-07 | — | |
| 8-K | — | 2024-03-07 | — | |
| 8-K | — | 2024-02-15 | 2024-02-14 | |
| 8-K | — | 2024-02-06 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-09 | — | |
| 8-K | — | 2023-09-07 | 2023-09-06 | |
| 8-K | — | 2023-08-10 | — | |
| 10-Q | — | 2023-08-10 | 2023-06-30 | |
| ARS | — | 2023-07-27 | 2022-12-31 | |
| DEFA14A | — | 2023-07-27 | — | |
| DEF 14A | — | 2023-07-27 | — | |
| PRE 14A | — | 2023-07-11 | — | |
| 8-K | — | 2023-06-21 | — | |
| 8-K | — | 2023-05-18 | — | |
| 8-K | — | 2023-05-11 | — | |
| 10-Q | — | 2023-05-11 | 2023-03-31 | |
| 10-K/A | — | 2023-04-27 | 2022-12-31 | |
| 10-K | — | 2023-03-09 | 2022-12-31 | |
| 8-K | — | 2023-03-09 | — | |
| 8-K | — | 2023-01-23 | — | |
| 10-Q | — | 2022-11-10 | 2022-09-30 | |
| 8-K | — | 2022-11-10 | — | |
| 8-K | — | 2022-10-31 | 2022-10-28 | |
| 8-K | — | 2022-10-28 | 2022-10-26 | |
| 8-K/A | — | 2022-09-30 | 2022-09-20 | |
| 8-K | — | 2022-09-26 | 2022-09-20 | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-08-11 | — | |
| 8-K | — | 2022-07-07 | 2022-07-05 | |
| 8-K | — | 2022-06-17 | 2022-06-16 | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| 8-K | — | 2022-05-12 | — | |
| 8-K | — | 2022-05-12 | 2022-05-11 | |
| DEF 14A | — | 2022-04-29 | — | |
| DEFA14A | — | 2022-04-29 | — | |
| 8-K | — | 2022-03-10 | — | |
| 10-K | — | 2022-03-10 | 2021-12-31 | |
| 8-K | — | 2022-02-14 | 2022-02-11 | |
| 8-K | — | 2021-12-21 | — | |
| 8-K | — | 2021-12-20 | 2021-12-17 | |
| 8-K | — | 2021-12-13 | — | |
| 8-K | — | 2021-11-10 | — | |
| 10-Q | — | 2021-11-10 | 2021-09-30 | |
| 8-K | — | 2021-09-30 | — | |
| 8-K | — | 2021-09-15 | 2021-09-13 | |
| DEFA14A | — | 2021-09-02 | — | |
| 8-K | — | 2021-08-12 | — | |
| 10-Q | — | 2021-08-12 | 2021-06-30 | |
| DEFA14A | — | 2021-08-03 | — |
Showing 51–100 of 137 filings
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
26 filings
26 filers
Visit website
Investor relations